| 摘要 |
<p>The present invention relates to pharmaceutical formulations comprising risperidone that shall be used in the treatment of schizophrenia, affective symptoms related to schizophrenia, manic episodes of bipolar disorder and restlessness related to autistic disorder.</p> |
